Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
19,800
Employees19,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
19,800
Employees19,800

EW Key Statistics

Market cap
50.76B
Market cap50.76B
Price-Earnings ratio
36.39
Price-Earnings ratio36.39
Dividend yield
Dividend yield
Average volume
3.34M
Average volume3.34M
High today
$85.73
High today$85.73
Low today
$83.50
Low today$83.50
Open price
$84.01
Open price$84.01
Volume
2.15M
Volume2.15M
52 Week high
$96.12
52 Week high$96.12
52 Week low
$60.57
52 Week low$60.57

EW News

Yahoo Finance 18h
Is Edwards Lifesciences Outperforming Other Medical Stocks This Year? - Yahoo Finance

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Edwards Lifesciences (EW) been one of th...

Is Edwards Lifesciences Outperforming Other Medical Stocks This Year? - Yahoo Finance
Yahoo Finance 18h
Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences - Yahoo Finance

Edwards Lifesciences (EW) has been beaten down lately with too much selling pressure. While the stock has lost 10.2% over the past four weeks, there is light at...

Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences - Yahoo Finance
Benzinga 18h
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'

Loading... Loading... On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifesciences Corporation EW is “pulling back here....

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'

Analyst ratings

53%

of 32 ratings
Buy
53.1%
Hold
40.6%
Sell
6.3%

More EW News

Yahoo Finance 2d
Edwards Lifesciences Corporation Q1 2024 Earnings Call Transcript - Yahoo Finance

Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript April 25, 2024 Edwards Lifesciences Corporation beats earnings expectations. Report...

Edwards Lifesciences Corporation Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance 3d
Investing in Edwards Lifesciences? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance

Have you looked into how Edwards Lifesciences (EW) performed internationally during the quarter ending March 2024? Considering the widespread global presence of...

Investing in Edwards Lifesciences? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Simply Wall St 3d
When Should You Buy Edwards Lifesciences Corporation? - Simply Wall St

Let's talk about the popular Edwards Lifesciences Corporation ( ). The company's shares saw a decent share price growth of 19% on the NYSE over the last few mon...

When Should You Buy Edwards Lifesciences Corporation? - Simply Wall St
Simply Wall St 5d
Edwards Lifesciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Edwards Lifesciences (NYSE:EW) First Quarter 2024 Results Key Financial Results Revenue: US$1.60b (up 9.5% from 1Q 2023). Net income: US$351.9m (up 3.3% from...

Edwards Lifesciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo Finance 6d
Edwards Lifesciences Q1 Earnings Top, 2024 Sales View Up - Yahoo Finance

Edwards Lifesciences Corporation EW reported adjusted earnings per share (EPS) of 66 cents in first-quarter 2024, surpassing the Zacks Consensus Estimate by 3.1...

Edwards Lifesciences Q1 Earnings Top, 2024 Sales View Up - Yahoo Finance
TipRanks 6d
Edwards Lifesciences price target lowered to $85 from $86 at Canaccord

Canaccord lowered the firm’s price target on Edwards Lifesciences to $85 from $86 and keeps a Buy rating on the shares. The firm said TAVR sales were slightly b...

Yahoo Finance 6d
Compared to Estimates, Edwards Lifesciences Q1 Earnings: A Look at Key Metrics - Yahoo Finance

Edwards Lifesciences (EW) reported $1.6 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 9.5%. EPS of $0.66 for th...

Compared to Estimates, Edwards Lifesciences Q1 Earnings: A Look at Key Metrics - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.